Market Tracker

06/22 5:15pm ET

Novo Nordisk A/S (NYSE:NVO)

46.84
Delayed Data
As of Jun 22
 +0.44 / +0.95%
Today’s Change
41.03
Today|||52-Week Range
58.37
-12.73%
Year-to-Date

Today’s Trading

Previous close46.40
Today’s open46.85
Day’s range46.41 - 47.00
Volume2,060,678
Average volume (3 months)1,505,918
Market cap$92.8B
Data as of 4:02pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+6.29%
Earnings growth (this year)+3.34%
Earnings growth (next 5 years)+6.02%
Revenue growth (last year)+3.25%
P/E ratio19.0
Price/Sales7.77
Price/Book15.20

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-0.15-0.17%
ABTAbbott Laboratories+0.19+0.31%
GSKGlaxoSmithKline+0.08+0.20%
BMYBristol-Myers Squibb+1.20+2.22%
Data as of 4:04pm ET, 06/22/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)$0.66
Annual revenue (last year)$17.1B
Annual profit (last year)$5.8B
Net profit margin34.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts